Wall Street's Lates...
Health Care: Drugs
NPS Pharmaceuticals Inc (NPSP: NASDAQ)
$7.45 -0.27 | -3.50%
02/10/12 - 11:28 AM ET
186.08K / 1.38M
Vol / Avg. Vol:7.69 / 7.72
Open / Prev. Close:7.43 - 7.70
Today's Range:4.35 - 10.75
52 Wk Range:18.97%
Performance YTD:TheStreet Rating:
Portfolios with NPSP
- Portfolio NameUser Type
- Userchinahound2
- ContributorBreakout Stocks Of The Week...
- Usersalvatore Portfolio 1
- UserRocket Stocks for the week ...
- UserNICAZ
- UserRocket Stocks for the week ...
- ContributorCharts of the Week - 2-03-2009
- Usertuna's picks
- UserRAPTOR SPRTD-1010081910
- UserRAPTOR 230 SPRTD
Latest NPSP Headlines from TheStreet
- Stocks Under $10: Value Biotech Stock
11.08.11 | 02:11 pm - NPS Stock Falls On Unusually High Volume (NPSP) 11.07.11 | 01:11 pm
- Phase III a success for Rare Endocrine Disease Drug. Will Investors Agree? 11.07.11 | 01:11 pm
- NPS Pharma: Another Phase III Success 11.07.11 | 07:11 am
- NPS Stock Gaps Down On Today's Open (NPSP) 10.31.11 | 10:10 am
- NPS Pharma: Positive Gattex Data Presented 05.10.11 | 09:05 am
- Biotech Calendar: Key Dates for May 05.02.11 | 09:05 am
- 5 Stocks Setting Up to Break Out 04.29.11 | 02:04 pm
- Biotech Stock Mailbag: Derma Sciences 02.04.11 | 07:02 am
- DepoMed, NPS Pharma: Small-Cap Winners 01.31.11 | 11:01 am
Press Releases for NPSP
- NPS Pharmaceuticals To Report 2011 Financial Results - Business Wire 02.08.12 | 04:02 pm
- NPS Pharmaceuticals To Present At Upcoming Conferences - Business Wire 02.06.12 | 04:02 pm
- NPS Pharmaceuticals Announces FDA Acceptance Of New Drug Application For GATTEX® (teduglutide) For The Treatment Of Adult Short Bowel Syndrome (SBS) - Business Wire 01.31.12 | 08:01 am
- NPS Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.05.12 | 04:01 pm
- NPS Pharmaceuticals Completes Submission Of New Drug Application For GATTEX® (teduglutide) In Adult Short Bowel Syndrome (SBS) - Business Wire 12.01.11 | 08:12 am
- NPS Pharmaceuticals To Present At Deutsche Bank BioFEST Conference - Business Wire 11.29.11 | 04:11 pm
- NPS Pharmaceuticals To Present At Lazard Capital Markets Healthcare Conference - Business Wire 11.09.11 | 04:11 pm
- NPS Pharmaceuticals Announces Positive Top-Line Results From Pivotal Phase 3 REPLACE Study Of NPSP558 In Hypoparathyroidism - Business Wire 11.07.11 | 06:11 am
- NPS Pharmaceuticals Announces NASDAQ Opening Bell Ceremony - Business Wire 11.04.11 | 08:11 am
- NPS Pharmaceuticals Reports Third Quarter 2011 Financial Results And Improves Cash Burn Guidance - Business Wire 11.03.11 | 08:11 am
Partner Headlines for NPSP
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- End-of-Day Market Summary for October 31, 2011 - Benzinga 10.31.11 | 04:10 pm
- Spectrum Pharmaceuticals: A Great Biotech Company For Around $8 - Seeking Alpha 08.26.11 | 05:08 am
- Top 20 Oversold Stocks Being Bought by Smart Money - Seeking Alpha 11.24.10 | 09:11 am
- 14 Short Ideas for Next Week - Seeking Alpha 09.10.10 | 06:09 pm
- Best Performing Russell 3000 Stocks Year to Date - SeekingAlpha.com 04.22.10 | 04:04 am
- NPS Pharmaceuticals: Good News on Horizon? - SeekingAlpha.com 03.26.10 | 10:03 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.18.10 | 08:03 am
